NEXGENIA INC.
Profile
Company Names
NEXGENIA INC.
Addresses
454 NORTH 34TH ST., SUITE LL, SEATTLE, WA 98103
NEW VENTURES FACILITY, FLUKE HALL, 4000 MASON ROAD, PO BOX 352141, SEATTLE, WA 98195
Phone Numbers
206-290-8902
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$4,096,568.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-05-08
$119,099.00
$250,000.00
$130,901.00
Debt
4
2017-03-23
$0.00
$1,900.00
$1,900.00
3
2016-08-05
$1,859,887.00
$2,000,000.00
$140,113.00
Equity
2
2015-06-17
$1,617,582.00
$3,547,583.00
$1,930,001.00
Equity
1
2014-10-14
$500,000.00
$1,000,000.00
$500,000.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN
GILLIS
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
